ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:A-Share Information
ag真人平台官方:H-Share Information
2024.03.15
ag真人平台官方:关于收到实际控制人先行垫付款项的公告
2024.03.15
DATE OF BOARD MEETING
2024.03.15
INSIDE INFORMATION ANNOUNCEMENT
2024.02.05
ag真人平台官方:关于深圳证监局对公司采取责令改正措施决定的公告
2024.02.05
ag真人平台官方:第六届监事会第五次会议决议公告
2024.02.05
ag真人平台官方:第六届董事会第八次会议决议公告
2024.02.05
ag真人平台官方:关于深圳证监局对公司采取责令改正措施决定的整改报告
2024.02.01
INSIDE INFORMATION ANNOUNCEMENT COMMENCEMENT OF INDEPENDENT THIRD PARTY INVESTIG...
2024.02.01
PROFIT WARNING ANNOUNCEMENT OF PROPOSED PROVISION FOR INVENTORY IMPAIRMENT IN 20...
2024.02.01
ESTIMATED ANNUAL RESULTS FOR 2023
第一页
上一页
4
5
6
7
8
下一页
最后一页
About Hepalink
Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
Our Businesses
ag真人平台官方:Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Official WeChat Account
ag真人平台官方:Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.